American Healthcare REIT (AHR) Stock Overview
A Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
AHR Community Fair Values
Create NarrativeSee what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
American Healthcare REIT, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$47.48 |
| 52 Week High | US$54.67 |
| 52 Week Low | US$34.72 |
| Beta | 0.81 |
| 1 Month Change | -5.08% |
| 3 Month Change | -7.82% |
| 1 Year Change | 33.82% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 259.15% |
Recent News & Updates
Narrative Update • Jun 03
AHR: Equity Offering And Lower Impairments Will Support Future Earnings
Narrative Update on American Healthcare REIT The analyst price target for American Healthcare REIT has shifted modestly to about $58.85 from roughly $58.08, with analysts pointing to small adjustments in the discount rate, profit margin expectations, and future P/E assumptions to support the new view. What’s in the News American Healthcare REIT priced an underwritten public offering of 14,000,000 common shares, expected to generate approximately US$705.6 million in gross proceeds, with BofA Securities as underwriter and a 30 day option to purchase an additional 2,100,000 shares.Seeking Alpha • May 19
American Healthcare REIT Is Capitalizing On Extremely Favorable Fundamentals
Summary American Healthcare REIT is positioned to benefit from a multi-year supply-demand imbalance in senior housing, supporting robust occupancy and rent growth. AHR's double-digit NFFO and SPNOI growth, combined with a healthy acquisition pipeline and declining leverage, underpin expectations for mid-teens total returns. Trading at ~24x 2026 NFFO, AHR is a value play among senior housing REITs, with a well-covered 2% dividend yield and strong organic and external growth prospects. The primary risk is AHR's reliance on a high equity multiple for external growth, but strong fundamentals and favorable demographics support continued outperformance. Read the full article on Seeking AlphaNarrative Update • May 16
AHR: Improved Impairment Profile And Equity Access Will Support Earnings Outlook
Analysts have inched their price target on American Healthcare REIT up to about $58. This reflects updated views on slightly higher profit margins, a revised discount rate, and adjusted expectations for revenue growth and future P/E.Recent updates
Narrative Update • Jun 03
AHR: Equity Offering And Lower Impairments Will Support Future Earnings
Narrative Update on American Healthcare REIT The analyst price target for American Healthcare REIT has shifted modestly to about $58.85 from roughly $58.08, with analysts pointing to small adjustments in the discount rate, profit margin expectations, and future P/E assumptions to support the new view. What’s in the News American Healthcare REIT priced an underwritten public offering of 14,000,000 common shares, expected to generate approximately US$705.6 million in gross proceeds, with BofA Securities as underwriter and a 30 day option to purchase an additional 2,100,000 shares.Seeking Alpha • May 19
American Healthcare REIT Is Capitalizing On Extremely Favorable Fundamentals
Summary American Healthcare REIT is positioned to benefit from a multi-year supply-demand imbalance in senior housing, supporting robust occupancy and rent growth. AHR's double-digit NFFO and SPNOI growth, combined with a healthy acquisition pipeline and declining leverage, underpin expectations for mid-teens total returns. Trading at ~24x 2026 NFFO, AHR is a value play among senior housing REITs, with a well-covered 2% dividend yield and strong organic and external growth prospects. The primary risk is AHR's reliance on a high equity multiple for external growth, but strong fundamentals and favorable demographics support continued outperformance. Read the full article on Seeking AlphaNarrative Update • May 16
AHR: Improved Impairment Profile And Equity Access Will Support Earnings Outlook
Analysts have inched their price target on American Healthcare REIT up to about $58. This reflects updated views on slightly higher profit margins, a revised discount rate, and adjusted expectations for revenue growth and future P/E.Narrative Update • Apr 24
AHR: Expanded Equity Access Will Support Earnings Outlook Through Leadership Change
Analysts have made a slight trim to their price target on American Healthcare REIT to $57.92 from $58.08, linking the update to revised assumptions for higher revenue growth, a more modest profit margin, and a similar forward P/E outlook. What's in the News Filed a follow-on equity offering of up to US$1.75 billion in common stock as an at-the-market program, signaling potential ongoing access to equity capital (Key Developments).Narrative Update • Apr 10
AHR: Expanded Equity Access Will Support Earnings Outlook Through Leadership Change
Analysts have reaffirmed their price target on American Healthcare REIT at $58.08 per share, citing largely unchanged fair value, growth, margin and P/E assumptions, with only minor tweaks to the discount rate and long term inputs. What's in the News Filed a follow on equity offering for up to US$1.75b of common stock through an at the market program, giving the company additional access to equity capital if it chooses to issue shares (Key Developments).Narrative Update • Mar 26
AHR: Expanded Equity Program Will Support Earnings Outlook Despite Leadership Transition
Analysts have nudged their price target for American Healthcare REIT slightly higher to about $58.08 from roughly $57.62, reflecting updated assumptions that include a modestly different revenue growth outlook, a higher projected profit margin, and a slightly lower future P/E multiple. What's in the News American Healthcare REIT completed a follow on equity offering totaling about $769.9m across multiple tranches of common stock, including offerings of 2,455,858 shares at $40.96, 5,866,000 shares at $42.61, 659,504 shares at $49.22, and 6,611,272 shares at $48.16, conducted as an at the market program (Key Developments).Narrative Update • Mar 11
AHR: Equity Offerings And Leadership Shift Will Shape Balanced Forward Outlook
Analysts have raised their price target on American Healthcare REIT by about $1.54 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and expected future P/E. What's in the News American Healthcare REIT completed a follow on equity offering totaling about $769.9m across multiple tranches of common stock, including 2,455,858 shares at $40.96, 5,866,000 shares at $42.61, 659,504 shares at $49.217375, and 6,611,272 shares at $48.162553 in an at the market structure (Key Developments).Narrative Update • Feb 25
AHR: Leadership Transition And Stable Assumptions Will Shape Forward Opportunity
Analysts have kept their price target for American Healthcare REIT effectively unchanged at about $56.08 per share, reflecting only minor adjustments to their discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News American Healthcare REIT, Inc.Narrative Update • Feb 10
AHR: Follow-On Equity Offering Will Support 2025 Guidance And Future Upside
Analysts have nudged their price target on American Healthcare REIT slightly higher to about US$56.08 from roughly US$56, citing modest adjustments to discount rate, revenue growth and profit margin assumptions, while keeping the forward P/E view broadly unchanged. What's in the News CEO and President Danny Prosky has taken a medical leave of absence effective February 3, 2026, following a recent medical event.Narrative Update • Jan 27
AHR: Follow-On Offering Will Support 2025 Guidance And Future Upside
Analysts have trimmed their price target on American Healthcare REIT slightly to about US$56, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a lower future P/E multiple. What's in the News American Healthcare REIT filed a follow-on equity offering of 8,100,000 common shares of its common stock.Narrative Update • Jan 11
AHR: Follow-On Equity Offering Will Support Raised Guidance And Future Upside
Analysts have kept their fair value estimate for American Healthcare REIT steady at US$56.08 per share, citing relatively unchanged assumptions for revenue growth, profit margin and future P/E, along with a slightly adjusted discount rate. What's in the News Completed a follow-on equity offering of 8,100,000 common shares at US$47.75 per share, raising about US$386.775 million (Follow on Equity Offerings) Filed follow-on equity offering documents for 8,100,000 common shares of American Healthcare REIT, Inc.Narrative Update • Dec 24
AHR: Follow-On Equity Offering And Raised Guidance Will Drive Future Upside
Analysts have modestly raised their price target on American Healthcare REIT by approximately 0.1 percent to about $56.08. This reflects slightly improved views on discount rates and long term profit margins, while leaving their fair value estimate effectively unchanged.Narrative Update • Dec 10
AHR: Follow-On Equity Offering Will Support Future Upside Potential
Analysts have slightly lowered their price target on American Healthcare REIT to approximately $56.08 per share from about $56.08 per share, reflecting marginally reduced discount rate and future P/E assumptions while maintaining largely unchanged growth and profitability expectations. What's in the News Completed a follow on equity offering of 8,100,000 common shares at $47.75 per share, raising approximately $386.8 million, with the securities structured as an income trust (Key Developments) Filed a follow on equity offering for 8,100,000 shares of common stock, signaling plans to access additional equity capital (Key Developments) Recorded consolidated impairment charges of $3.8 million on real estate investments for the quarter ended September 30, 2025, reflecting write downs on certain properties (Key Developments) Raised full year 2025 guidance, increasing expected diluted EPS to $0.47 to $0.50, same store NOI growth to 13.0 to 15.0 percent, and net income attributable to common stockholders to $78 million to $83 million (Key Developments) Valuation Changes Fair Value Estimate remains unchanged at approximately $56.08 per share, indicating no revision to the intrinsic value assessment.Narrative Update • Nov 26
AHR: Upcoming Equity Offerings And Raised Guidance Will Drive Momentum
Analysts have raised their price target for American Healthcare REIT from $48.73 to $56.08. They cite a significantly improved revenue growth outlook, even though profit margin projections have been reduced.Narrative Update • Nov 12
AHR: Improved Profit Margins And Lower Discount Rate Will Support Outlook
Analysts have raised their price target for American Healthcare REIT from $46.92 to $48.73. They cite improved profit margins and a lower discount rate as key factors behind the positive revision.Narrative Update • Oct 28
Outlook Will Strengthen As Capital Access And Deal Pipeline Expand
Analysts have slightly increased their price target for American Healthcare REIT, raising it from $46.75 to $46.92. Minor adjustments in key financial assumptions suggest a modestly improved outlook for the company.Narrative Update • Oct 14
Low Supply And Value-Based Care Will Drive Senior Markets
Analysts have raised their price target for American Healthcare REIT from $46.00 to $46.75, citing slight improvements in profit margin forecasts and a marginally higher fair value projection. What's in the News American Healthcare REIT, Inc.Narrative Update • Aug 27
Low Supply And Value-Based Care Will Drive Senior Markets
Despite a notable decline in net profit margin and a sharp increase in future P/E, analysts have raised their fair value target for American Healthcare REIT from $42.45 to $45.27. What's in the News Management reports strong organic earnings growth and a robust pipeline, with over $300 million in awarded deals, focusing acquisitions on high-quality long-term care assets under the RIDEA structure.New Narrative • Jul 16
Senior Care Demand And Capital Recycling Will Empower Future Markets
Rising demand for senior care and strategic asset recycling are driving sustained revenue, margin, and earnings growth, supported by favorable demographic trends and limited new supply.Seeking Alpha • Mar 25
American Healthcare REIT Has Growth Potential But Is A Hold Due To Valuation
Summary American Healthcare REIT is a diversified REIT focusing on senior care properties, showing strong growth and benefiting from the aging population trend. AHR's recent performance includes an 8.5% same-store growth and a 21.6% increase in Net Operating Income in Q4 2024. Valuation using the dividend discount model suggests a $30.00 share value, indicating a 0.54% upside, leading to a "hold" recommendation. Risks include high debt and potential interest rate increases, impacting expansion costs and overall profitability. Read the full article on Seeking AlphaSeeking Alpha • Oct 03
American Healthcare REIT: Capitalizing On Supply And Demand Imbalance In Healthcare Real Estate
Summary American Healthcare REIT is a top choice due to its diverse portfolio, strong management, and strategic capital allocation, benefiting from demographic tailwinds and supply-demand imbalances. The REIT's business model focuses on long-term leases with experienced healthcare operators, ensuring reliable revenue and resilience across various property types. Improving occupancy rates, disciplined capital allocation, and a solid balance sheet position American Healthcare REIT for sustained growth and attractive returns. With a reasonable valuation at 17.4x forward FFO, I rate American Healthcare REIT as a 'buy' as it looks to benefit from long-term healthcare facility demand. Read the full article on Seeking AlphaSeeking Alpha • Jul 12
American Healthcare REIT Set To Grow With Demographic Tailwinds And Expansion
Summary AHR focuses on nursing homes and health infrastructure, utilizing both triple-net leases and RIDEA properties for operational upside. Demographic tailwinds and cost improvements support long-term growth potential for AHR, with a 6.5% yield. AHR's estimated fair value is $19.50, with strong market conditions and potential for future growth in the healthcare sector. Read the full article on Seeking AlphaShareholder Returns
| AHR | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | -2.9% | -0.7% | -2.9% |
| 1Y | 33.8% | 25.8% | 23.5% |
Return vs Industry: AHR exceeded the US Health Care REITs industry which returned 24% over the past year.
Return vs Market: AHR exceeded the US Market which returned 26.3% over the past year.
Price Volatility
| AHR volatility | |
|---|---|
| AHR Average Weekly Movement | 4.3% |
| Health Care REITs Industry Average Movement | 4.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AHR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AHR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 121 | Jeff Hanson | www.americanhealthcarereit.com |
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure.
American Healthcare REIT, Inc. Fundamentals Summary
| AHR fundamental statistics | |
|---|---|
| Market cap | US$9.03b |
| Earnings (TTM) | US$100.32m |
| Revenue (TTM) | US$2.37b |
91.2x
P/E Ratio3.9x
P/S RatioIs AHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AHR income statement (TTM) | |
|---|---|
| Revenue | US$2.37b |
| Cost of Revenue | US$1.92b |
| Gross Profit | US$446.80m |
| Other Expenses | US$346.48m |
| Earnings | US$100.32m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.52 |
| Gross Margin | 18.84% |
| Net Profit Margin | 4.23% |
| Debt/Equity Ratio | 43.9% |
How did AHR perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield52%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/05 05:17 |
| End of Day Share Price | 2026/06/05 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
American Healthcare REIT, Inc. is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anthony Powell | Barclays |
| Juan Sanabria | BMO Capital Markets Equity Research |
| John Kim | BMO Capital Markets Equity Research |